Total Number of Communication Reports: 0
Monthly communication reports in the last 6 months: 0
Subject matters | Details | Categories |
---|---|---|
Health, Industry, Research and Development
|
Eligibility for Scientific Research and Experimental Development tax incentives.
|
Grant, Contribution or Other Financial Benefit
|
Government Procurement, Health, Industry, Research and Development
|
Seek funding support from the Strategic Innovation Fund to expand Emergent's Winnipeg facility.
|
Grant, Contribution or Other Financial Benefit
|
Aboriginal Affairs, Consumer Issues, Defence, Government Procurement, Health, Justice and Law Enforcement, Research and Development
|
To work with government to make NARCAN® (Naloxone HCI) Nasal Spray more widely available across Canada to facilitate immediate treatment to individuals suffering from opioid overdose.
|
Policies or Program
|
Address:
2476 Argentia, Suite 403
Mississauga, ON L5N 6M1
Canada
Telephone number:
204-275-4200
Web address:
www.emergentbiosolutions.com
David Renwick, General Manager, Canada
Emergent BioSolutions Canada Inc. is not a coalition.
The activities of Emergent BioSolutions Canada Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Emergent BioSolutions Canada Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Alexander MacDonald | Public offices held
Firm: Counsel Public Afairs Inc